Walter Toro Jimenez, MD

Novartis Pharmaceuticals Corporation

Poster(s):

• (74) Longitudinal assessment of treatment costs in patients with spinal muscular atrophy receiving disease-modifying therapies
  Wednesday, October 29, 2025